Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells - PubMed (original) (raw)
. 2008 Sep 15;112(6):2340-52.
doi: 10.1182/blood-2008-01-133967. Epub 2008 Jul 10.
Affiliations
- PMID: 18617638
- DOI: 10.1182/blood-2008-01-133967
Free article
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
Hans J P M Koenen et al. Blood. 2008.
Free article
Abstract
The effector T-cell lineage shows great plasticity. Th17 cells are acknowledged to be instrumental in the response against microbial infection, but are also associated with autoimmune inflammatory processes. Here, we report that human regulatory T cells (CD4(pos)CD25(high)Foxp3(pos)CD127(neg)CD27(pos)) can differentiate into IL-17-producing cells, when stimulated by allogeneic antigen-presenting cells, especially monocytes, in the presence of rhIL-2/rhIL-15. These regulatory T cell (Treg)-derived IL-17-producing cells showed high expression of the Th17-related transcription factor RORgammat and were positively identified by CCR6 expression. This differentiation process was enhanced by exogenous IL-1beta, IL-23, and IL-21, whereas IL-6 or TGFbeta did not affect the emergence of IL-17-producing cells. The addition of IL-1 receptor antagonist (IL-1Ra), but not anti-IL-23 antibody, reduced IL-17-producing cell numbers. When an histone deacetylase (HDAC) inhibitor trichostatin A (TSA) was evaluated, we found a profound negative effect on the emergence of IL-17-producing cells from Tregs, implying that Treg differentiation into IL-17-producing cells depends on histone/protein deacetylase activity. Thus, the data suggest that epigenetic modification underlies the phenomenon of Treg plasticity here described.
Similar articles
- Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, Koenen HJ. Bovenschen HJ, et al. J Invest Dermatol. 2011 Sep;131(9):1853-60. doi: 10.1038/jid.2011.139. Epub 2011 Jun 9. J Invest Dermatol. 2011. PMID: 21654831 - Identification of IL-17-producing FOXP3+ regulatory T cells in humans.
Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ. Voo KS, et al. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4793-8. doi: 10.1073/pnas.0900408106. Epub 2009 Mar 9. Proc Natl Acad Sci U S A. 2009. PMID: 19273860 Free PMC article. - Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors.
Valmori D, Raffin C, Raimbaud I, Ayyoub M. Valmori D, et al. Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19402-7. doi: 10.1073/pnas.1008247107. Epub 2010 Oct 20. Proc Natl Acad Sci U S A. 2010. PMID: 20962281 Free PMC article. - Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B. Kristensen B. Dan Med J. 2016 Feb;63(2):B5177. Dan Med J. 2016. PMID: 26836805 Review. - Histone deacetylase inhibitors and transplantation.
Tao R, de Zoeten EF, Ozkaynak E, Wang L, Li B, Greene MI, Wells AD, Hancock WW. Tao R, et al. Curr Opin Immunol. 2007 Oct;19(5):589-95. doi: 10.1016/j.coi.2007.07.015. Epub 2007 Aug 24. Curr Opin Immunol. 2007. PMID: 17719760 Free PMC article. Review.
Cited by
- Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Anvar MT, Rashidan K, Arsam N, Rasouli-Saravani A, Yadegari H, Ahmadi A, Asgari Z, Vanan AG, Ghorbaninezhad F, Tahmasebi S. Anvar MT, et al. Cancer Cell Int. 2024 Oct 27;24(1):355. doi: 10.1186/s12935-024-03525-9. Cancer Cell Int. 2024. PMID: 39465401 Free PMC article. Review. - Effector memory-type regulatory T cells display phenotypic and functional instability.
Wendering DJ, Amini L, Schlickeiser S, Farrera-Sal M, Schulenberg S, Peter L, Mai M, Vollmer T, Du W, Stein M, Hamm F, Malard A, Castro C, Yang M, Ranka R, Rückert T, Durek P, Heinrich F, Gasparoni G, Salhab A, Walter J, Wagner DL, Mashreghi MF, Landwehr-Kenzel S, Polansky JK, Reinke P, Volk HD, Schmueck-Henneresse M. Wendering DJ, et al. Sci Adv. 2024 Sep 6;10(36):eadn3470. doi: 10.1126/sciadv.adn3470. Epub 2024 Sep 4. Sci Adv. 2024. PMID: 39231218 Free PMC article. - The Complex Dysregulations of CD4 T Cell Subtypes in HIV Infection.
Tolomeo M, Cascio A. Tolomeo M, et al. Int J Mol Sci. 2024 Jul 9;25(14):7512. doi: 10.3390/ijms25147512. Int J Mol Sci. 2024. PMID: 39062756 Free PMC article. Review. - A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis.
Thonhoff JR, Beers DR, Zhao W, Faridar A, Thome A, Wen S, Zhang A, Wang J, Appel SH. Thonhoff JR, et al. Front Neurol. 2024 Jun 10;15:1415106. doi: 10.3389/fneur.2024.1415106. eCollection 2024. Front Neurol. 2024. PMID: 38915796 Free PMC article. - Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review.
Khokhar M, Dey S, Tomo S, Jaremko M, Emwas AH, Pandey RK. Khokhar M, et al. ACS Pharmacol Transl Sci. 2024 May 28;7(6):1664-1693. doi: 10.1021/acsptsci.4c00067. eCollection 2024 Jun 14. ACS Pharmacol Transl Sci. 2024. PMID: 38898941 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials